ranolazine has been researched along with Invasiveness, Neoplasm in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Djamgoz, MBA; Fraser, SP; Lee, A | 1 |
| Besson, P; Bon, E; Bougnoux, P; Chevalier, S; Collin, C; Driffort, V; Gillet, L; Joulin, V; Jourdan, ML; Le Guennec, JY; Marionneau-Lambot, S; Oullier, T; Pagès, JC; Roger, S | 1 |
| Castellino, FJ; Gutierrez, LS; Navari, RM; Paoni, NF; Pollard, M; Risatti, CA; Suckow, MA; Taylor, RE; Wolter, WR | 1 |
3 other study(ies) available for ranolazine and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Propranolol inhibits neonatal Nav1.5 activity and invasiveness of MDA-MB-231 breast cancer cells: Effects of combination with ranolazine.
Topics: Cell Movement; Cell Proliferation; Collagen; Drug Combinations; Female; Gene Expression Regulation, Neoplastic; Humans; Laminin; NAV1.5 Voltage-Gated Sodium Channel; Neoplasm Invasiveness; Potassium Channels, Voltage-Gated; Propranolol; Proteoglycans; Ranolazine; Receptors, Adrenergic, beta; Triple Negative Breast Neoplasms; Tumor Hypoxia | 2019 |
Ranolazine inhibits NaV1.5-mediated breast cancer cell invasiveness and lung colonization.
Topics: Acetanilides; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Female; Humans; Lung; Mice; Mice, Nude; NAV1.5 Voltage-Gated Sodium Channel; Neoplasm Invasiveness; Neoplasm Metastasis; Piperazines; Ranolazine | 2014 |
The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice.
Topics: Acetanilides; Adenomatous Polyposis Coli; Alleles; Animals; Carcinogens; Disease Progression; Dose-Response Relationship, Drug; Enzyme Inhibitors; Genes, APC; Injections, Intraperitoneal; Intestinal Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Invasiveness; Piperazines; Ranolazine | 2004 |